Australian shares have shown modest gains recently, with the ASX 200 futures indicating a slight upward trend amid ongoing geopolitical uncertainties. In this context, penny stocks—often associated with smaller or newer companies—remain an intriguing area for investors seeking growth opportunities. While the term may seem outdated, these stocks can still offer significant potential when backed by strong financial health and strategic positioning.

Top 10 Penny Stocks In Australia

Name Share Price Market Cap Financial Health Rating West African Resources (ASX:WAF) A$3.03 A$3.46B ★★★★★★ LaserBond (ASX:LBL) A$0.57 A$67.37M ★★★★★★ Regal Partners (ASX:RPL) A$2.47 A$912.42M ★★★★★★ Praemium (ASX:PPS) A$0.66 A$321.73M ★★★★★★ Australian Ethical Investment (ASX:AEF) A$4.41 A$501.99M ★★★★★★ EDU Holdings (ASX:EDU) A$0.74 A$92.46M ★★★★★★ Integrated Research (ASX:IRI) A$0.30 A$54.18M ★★★★★★ Kingsgate Consolidated (ASX:KCN) A$4.31 A$1.15B ★★★★★★ CTI Logistics (ASX:CLX) A$1.825 A$143.26M ★★★★☆☆ Cogstate (ASX:CGS) A$2.23 A$381.03M ★★★★★★

Click here to see the full list of 399 stocks from our ASX Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

DroneShield

Simply Wall St Financial Health Rating: ★★★★★★

Overview: DroneShield Limited focuses on developing, commercializing, and selling counter-drone hardware and software technology globally, with a market cap of A$4.13 billion.

Operations: The company's revenue is primarily derived from its Aerospace & Defense segment, totaling A$216.81 million.

Market Cap: A$4.13B

DroneShield Limited has demonstrated significant financial growth, reporting A$216.55 million in sales for 2025, up from A$57.53 million the previous year, and achieving profitability with a net income of A$3.52 million. The company benefits from strong short-term asset coverage over liabilities and is debt-free, enhancing its financial stability. However, its share price remains highly volatile compared to most Australian stocks. Recent leadership changes aim to support global expansion amid rising demand across defense sectors in Europe and the U.S., potentially strengthening operational capabilities despite a relatively inexperienced management team with an average tenure of 0.8 years.

Click here to discover the nuances of DroneShield with our detailed analytical financial health report. Learn about DroneShield's future growth trajectory here.ASX:DRO Financial Position Analysis as at Mar 2026

Deep Yellow

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Deep Yellow Limited, along with its subsidiaries, focuses on acquiring, exploring, developing, and evaluating uranium properties in Australia and Namibia, with a market cap of A$1.70 billion.

Story Continues

Operations: Deep Yellow Limited does not report any revenue segments.

Market Cap: A$1.7B

Deep Yellow Limited, with a market cap of A$1.70 billion, is transitioning from a uranium developer to producer, highlighted by recent leadership changes including the appointment of Greg Field as CEO and Jennifer Mintz as Chief Legal Officer. The company remains pre-revenue but has become profitable over the past year. It benefits from stable weekly volatility and strong asset coverage over liabilities without any debt burden. However, earnings are forecasted to decline significantly in the next three years despite anticipated revenue growth. The board is experienced, though management's average tenure suggests a relatively new team.

Unlock comprehensive insights into our analysis of Deep Yellow stock in this financial health report. Gain insights into Deep Yellow's outlook and expected performance with our report on the company's earnings estimates.ASX:DYL Debt to Equity History and Analysis as at Mar 2026

Nanosonics

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Nanosonics Limited is an infection prevention company with operations across Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific; it has a market cap of A$1.12 billion.

Operations: The company's revenue is derived from its healthcare equipment segment, totaling A$207.26 million.

Market Cap: A$1.12B

Nanosonics, with a market cap of A$1.12 billion, demonstrates financial stability through strong asset coverage over liabilities and no debt burden. The company's earnings grew by 24.1% last year, surpassing industry averages, supported by high-quality earnings and stable weekly volatility at 6%. Despite a low return on equity of 9.4%, Nanosonics' recent national agreement for its trophon®3 device could enhance revenue streams. However, the board's inexperience contrasts with an experienced management team averaging 3.8 years in tenure. Recent leadership additions aim to bolster strategic growth amid ongoing innovation in infection prevention technology.

Jump into the full analysis health report here for a deeper understanding of Nanosonics. Examine Nanosonics' earnings growth report to understand how analysts expect it to perform.ASX:NAN Debt to Equity History and Analysis as at Mar 2026

Key Takeaways

Navigate through the entire inventory of 399  ASX Penny Stocks here. Searching for a Fresh Perspective? AI is about to change healthcare. These 125 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:DRO ASX:DYL and ASX:NAN.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments